Although overexpression of TIM‐4 leading to an increased proportion of Tregs was also observed in an in‐situ model of mouse pancreatic cancer (Figure 8), we cannot attribute the phenomenon in vivo solely to decreased IL‐6 secretion at present. The gene discussed is IL6; the disease is pancreatic neoplasm.